These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 3352795

  • 21. Oxygen enhancement ratio in V79 spheroids.
    Durand RE.
    Radiat Res; 1983 Nov; 96(2):322-34. PubMed ID: 6647761
    [Abstract] [Full Text] [Related]

  • 22. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.
    Frankel A, Buckman R, Kerbel RS.
    Cancer Res; 1997 Jun 15; 57(12):2388-93. PubMed ID: 9192815
    [Abstract] [Full Text] [Related]

  • 23. Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
    Bible KC, Kaufmann SH.
    Cancer Res; 1997 Aug 15; 57(16):3375-80. PubMed ID: 9269999
    [Abstract] [Full Text] [Related]

  • 24. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F, Duivenvoorden WC, Singh G.
    Anticancer Drugs; 2009 Feb 15; 20(2):115-22. PubMed ID: 19209028
    [Abstract] [Full Text] [Related]

  • 25. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation.
    Belfi CA, Chatterjee S, Gosky DM, Berger SJ, Berger NA.
    Biochem Biophys Res Commun; 1999 Apr 13; 257(2):361-8. PubMed ID: 10198218
    [Abstract] [Full Text] [Related]

  • 26. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K, Godwin AK, Yakushiji M, O'Dwyer PJ, Ozols RF, Hamilton TC.
    Cancer Res; 1993 Nov 01; 53(21):5225-32. PubMed ID: 8106143
    [Abstract] [Full Text] [Related]

  • 27. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
    Samimi G, Kishimoto S, Manorek G, Breaux JK, Howell SB.
    Cancer Chemother Pharmacol; 2007 Feb 01; 59(3):301-12. PubMed ID: 16770583
    [Abstract] [Full Text] [Related]

  • 28. Recovery from potentially lethal damage and recruitment time of noncycling clonogenic cells in 9L confluent monolayers and spheroids.
    Rodriguez A, Alpen EL, Mendonca M, DeGuzman RJ.
    Radiat Res; 1988 Jun 01; 114(3):515-27. PubMed ID: 3375440
    [Abstract] [Full Text] [Related]

  • 29. Potentiation of mitomycin C, 6-mercaptopurine, bleomycin, cis-diamminedichloroplatinum and 5-fluorouracil by mycotrienins and mycotrienols.
    Kuwano M, Ikezaki K, Mamizuka K, Komiyama S, Seto H, Otake N, Sugita M, Yamaguchi T, Kishiye T, Fukawa H.
    Gan; 1983 Oct 01; 74(5):759-66. PubMed ID: 6196249
    [Abstract] [Full Text] [Related]

  • 30. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O, Arce F, Gätjens-Boniche O, Díaz C.
    Biomed Pharmacother; 2007 Jul 01; 61(6):347-55. PubMed ID: 17399942
    [Abstract] [Full Text] [Related]

  • 31. Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin.
    Caney C, Singh G, Lukka H, Rainbow AJ.
    Int J Radiat Biol; 2004 Apr 01; 80(4):291-9. PubMed ID: 15204706
    [Abstract] [Full Text] [Related]

  • 32. Hypothermic modulation of doxorubicin, cisplatin and radiation cytotoxicity in vitro.
    Lundgren-Eriksson L, Hultborn R, Henriksson R.
    Anticancer Res; 2001 Apr 01; 21(5):3275-80. PubMed ID: 11848483
    [Abstract] [Full Text] [Related]

  • 33. Temperature dependence of adriamycin, cis-diamminedichloroplatinum, bleomycin, and 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity in vitro.
    Herman TS.
    Cancer Res; 1983 Feb 01; 43(2):517-20. PubMed ID: 6184147
    [Abstract] [Full Text] [Related]

  • 34. Cytotoxicity of several chemotherapeutic agents in a human pancreatic cancer cell line (Colo-357).
    Cadman E, Benz C.
    Cancer Treat Rep; 1984 Feb 01; 68(2):429-30. PubMed ID: 6697332
    [Abstract] [Full Text] [Related]

  • 35. Differential sensitivity to mitomycin C between human RSa cell line and its derivative UVr-1.
    Hiwasa T, Chen Z, Nomura J, Yamamori H, Tashiro T, Nakajima N, Suzuki N.
    Anticancer Res; 1999 Feb 01; 19(5B):3915-20. PubMed ID: 10628331
    [Abstract] [Full Text] [Related]

  • 36. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide.
    Yokomizo A, Ono M, Nanri H, Makino Y, Ohga T, Wada M, Okamoto T, Yodoi J, Kuwano M, Kohno K.
    Cancer Res; 1995 Oct 01; 55(19):4293-6. PubMed ID: 7671238
    [Abstract] [Full Text] [Related]

  • 37. [Effect of combined treatment with cisplatin and radiation on the survival of Chinese hamster cells].
    Ziegler W, Trott KR.
    Strahlentherapie; 1985 May 01; 161(5):308-15. PubMed ID: 4039857
    [Abstract] [Full Text] [Related]

  • 38. Multicell spheroid response to drugs predicted with the comet assay.
    Olive PL, Banáth JP.
    Cancer Res; 1997 Dec 15; 57(24):5528-33. PubMed ID: 9407963
    [Abstract] [Full Text] [Related]

  • 39. Cytotoxic effect of 5-thio-D-glucose on chronically hypoxic cells in multicell spheroids.
    Song CW, Sung JH, Clement JJ, Levitt SH.
    Br J Cancer Suppl; 1978 Jun 15; 3():136-40. PubMed ID: 277213
    [Abstract] [Full Text] [Related]

  • 40. [Anticancer drug induced sister chromatid exchange and correlation to cell survival in human brain tumor cells].
    Aida T, Bodell WJ.
    No To Shinkei; 1987 Mar 15; 39(3):235-41. PubMed ID: 3472531
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.